ContactDictionary

Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  methylprednisolone
Find trials that include:  Any drugs shown
Results 1-13 of 13 for your search:
Start Over
A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD
Status: Temporarily closed
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 471501, NCI-2016-01887, NCT02956122
Combination Chemotherapy and Total Body Irradiation in Treating Patients with Fanconi Anemia Undergoing Donor Stem Cell Transplant
Status: Active
Phase: Phase III, Phase II
Type: Treatment
Age: 17 and under
Trial IDs: MT2006-05, NCI-2017-01078, NCT00352976
Imatinib Mesylate and Combination Chemotherapy in Treating Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Not yet active
Phase: Phase III
Type: Treatment
Age: 2 to 21
Trial IDs: AALL1631, NCI-2016-01588, NCT03007147
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: INCB 39110-301, NCI-2017-01212, NCT03139604
Ruxolitinib Phosphate or Dasatinib with Chemotherapy in Treating Patients with Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 10 and over
Trial IDs: 2014-0521, NCI-2015-00779, NCT02420717
Idarubicin, Cytarabine, and Nivolumab in Treating Patients with High-Risk Acute Myeloid Leukemia or Myelodysplastic Syndrome
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 2014-0907, NCI-2015-01258, NCT02464657
Tretinoin and Arsenic Trioxide with or without Gemtuzumab Ozogamicin in Treating Patients with Previously Untreated Acute Myeloid Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: 10 and over
Trial IDs: 2010-0981, NCI-2011-02767, NCT01409161
Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients with Acute Lymphoblastic Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2011-0030, NCI-2011-02941, NCT01424982
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim in Treating Patients with Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
Status: Active
Phase: Phase II
Type: Treatment
Age: Not specified
Trial IDs: 2012-0334, NCI-2012-01096, NCT01624805
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low or Intermediate-Risk Hodgkin Lymphoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Not specified
Trial IDs: H-30993, NCI-2013-01346, TXCH-HD-12A, NCT01858922
Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: BL-8040.06, NCI-2015-01892, NCT02462252
A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH1)
Status: Active
Phase: Phase II
Type: Supportive care, Treatment
Age: 12 and over
Trial IDs: INCB 18424-271 (REACH1), NCI-2016-01824, INCB 18424-271, INCB 18424-271/REVERSE-1, NCT02953678
Carfilzomib and Hyper-CVAD in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 64
Trial IDs: UCDCC#246, NCI-2014-02245, NCT02293109
Start Over